GILD

Gilead Sciences, Inc. News Headlines

$72.86
*  
1.26
 negative 
1.76%
Get GILD Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Gilead Sciences Q1 Profit More Than Triples, Results Beat View
4/22/2014 8:46:00 PM - RTT News

Gilead Sciences Q1 Profit Rises; Reiterates 2014 Guidance
4/22/2014 6:02:00 PM - RTT News

Gilead Sciences' Results Boosted by Hepatitis C Drug -- 2nd Update
4/22/2014 5:14:00 PM - Dow Jones Business News

Gilead Sciences' Results Boosted by Hepatitis C Drug--2nd Update
4/22/2014 5:14:00 PM - Dow Jones Business News

After Hours Most Active for Apr 22, 2014 : CX, BTU, QQQ, CMCSA, T, GILD, AMX, INTC, C, AGN, HBAN, CREE
4/22/2014 4:44:35 PM - NASDAQ.com News

Rallying Ahead of Earnings
4/22/2014 3:58:00 PM - Fox Business

After-Hours Earnings Report for April 22, 2014 : T, GILD, AMGN, CNI, YUM, DFS, ILMN, ISRG, VMW, FTI, JNPR, BCR
4/22/2014 2:00:02 PM - NASDAQ.com News

Keep an Eye on these 3 Biotech Stocks - Earnings ESP
4/22/2014 11:49:01 AM - Zacks.com

Synageva Heading For Big Disappointment
4/22/2014 11:05:00 AM - Seeking Alpha

Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - Seeking Alpha

Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - SeekingAlpha

Gilead Sciences Q1 14 Earnings Conference Call At 4:15 PM ET
4/22/2014 6:52:00 AM - RTT News

Wall Street Turns Apprehensive Ahead Of Housing Data
4/22/2014 6:38:00 AM - RTT News

LLY Adds New Drug To Portfolio, GILD Faces FDA Decision, IMUC Catches Eyes
4/21/2014 10:53:00 PM - RTT News

Retail Investors Should Be Doing Valuations On Their Biotechs - The Market Is
4/21/2014 4:48:00 PM - Seeking Alpha

FDA Accepts Gilead's NDAs For Cobicistat And Elvitegravir For HIV Therapy
4/21/2014 4:47:00 PM - RTT News

After Hours Most Active for Apr 21, 2014 : BAC, C, NFLX, GS^I, AGN, FB, AMD, PT, QQQ, MSFT, GILD, WEN
4/21/2014 4:39:53 PM - NASDAQ.com News

Biotech Is Not A Popping Bubble: Buy The Dip While You Can
4/21/2014 2:34:00 PM - Seeking Alpha

Gilead Results Can Affect The Entire Market
4/21/2014 11:17:00 AM - Seeking Alpha

Why Gilead Sciences Is Heading To $80
4/21/2014 11:04:00 AM - Seeking Alpha

Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
4/21/2014 10:50:01 AM - Zacks.com

Speculative But Attractive Biotechs Insiders Are Buying
4/21/2014 10:12:00 AM - Seeking Alpha

Weekly CFO Sells Highlight: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan Chase & Co.
4/20/2014 5:11:28 PM - GuruFocus

MARKET SNAPSHOT: Long View On Stocks Is Best During Weak Earnings Season
4/20/2014 6:01:00 AM - Dow Jones Business News

Cohen’s Point72 Asset Management buys a stake in MacroGenics
4/18/2014 9:00:00 AM - Market Realist